Treace Medical Concepts, Inc. (TMCI) income statement
TMCINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3029% below fair value
$4.53+0.09 (+2.03%)
Close on Nov 18, 2026Market cap $294.61MP/E –Yield –
Treace Medical Concepts, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 79.5%
- Operating margin
- -26.2%
- Net margin
- -29.0%
- Return on equity, FY2025
- -58.9%
Financial strength
- Current ratio
- 2.90
- Debt to equity
- 0.87
- Debt to assets
- 32.7%
- Cash to current liabilities
- 30.4%
Valuation
- P/E ratio
- –
- Price to sales
- 1.43
- Price to book
- 4.35
- Dividend yield
- –
See a number that looks wrong?